Literature DB >> 24826971

Genomic breakthroughs in the diagnosis and treatment of cystic fibrosis.

Stephanie J Nakano1, Audrey Tluczek.   

Abstract

OVERVIEW: Cystic fibrosis (CF) is an autosomal recessive disorder that was long considered a terminal illness. Recent genetic discoveries and genomic innovations, however, have transformed the diagnosis, classification, and treatment of this multisystem condition. For affected patients, these breakthroughs offer hope for significantly greater longevity and quality of life and, perhaps, for a future cure. This article reviews empirical research on CF, filling a critical gap in the nursing literature regarding recent findings in the study of CF genetics and their implications for patient teaching, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2014        PMID: 24826971     DOI: 10.1097/01.NAJ.0000450425.66889.7e

Source DB:  PubMed          Journal:  Am J Nurs        ISSN: 0002-936X            Impact factor:   2.220


  1 in total

1.  Comparison of Vancomycin Pharmacokinetics in Cystic Fibrosis Patients Pre and Post-lung Transplant.

Authors:  Shannon White; Colleen Sakon; Linda Fitzgerald; Charissa Kam; Erin McDade; Alanna Wong
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.